Tevemyxine Collyre
Tevemyxine Collyre
Authorised
- Neomycin
- Polymyxin B
Product identification
Medicine name:
Tevemyxine Collyre
Active substance:
- Neomycin
- Polymyxin B
Target species:
-
Cat
-
Dog
Route of administration:
-
Ocular use
Product details
Active substance and strength:
-
Neomycin3400.00/international unit(s)1.00millilitre(s)
-
Polymyxin B10000.00/international unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Eye drops, powder and solvent for solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS01AA30
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Available in:
-
Luxembourg
Package description:
- Available only in French
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Domes Pharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Tubilux Pharma S.p.A.
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V 421/02/15/1505
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 22/10/2023